REMAP-CAP for COVID 19

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    APPRISE
  • Principal Investigator

    Steve Webb, Allen Cheng
  • Research Location

    United States of America, Canada
  • Lead Research Institution

    Monash University
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Clinical trials for disease management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

REMAP-CAP for COVID 19REMAP-CAP is an existing multi-site international adaptive platform trial that was predesigned to adapt in the event of a pandemic.ObjectivesGenerate evidence that can be applied to clinical practice during the pandemic, regarding the impact of multiple candidate interventions to reduce mortality or reduce the length of intensive care unit admission or both in critically ill patients with COVID-19 infection